Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2015

Canaccord Genuity Cuts Price Target on Neovasc (NVCN) to $9.50; Reiterates Buy

March 30, 2016 10:04 AM EDT

Canaccord Genuity maintained a Buy rating on Neovasc (NASDAQ: NVCN), and cut the price target to $9.50 (from $15.00). Cannaccord continues to see NVCN as an attractive long-term asset in the potentially huge Transcatheter mitral valve replacement (TMVR) space. However, clinical and market development hurdles remain for all, and enrollment in NVCNs TIARA-1... More

Neovasc (NVCN) Outpaces Q4 Loss Views

March 29, 2016 4:40 PM EDT

Neovasc (NASDAQ: NVCN) reported Q4 EPS of ($0.11), $0.04 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $2.24 million versus the consensus estimate of $3.26 million.

For earnings history and earnings-related data on Neovasc (NVCN) click here.

... More